Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to evaluate the effect of
Levemir® (insulin detemir) on glycaemic control, weight and incidence of hypoglycaemic events
in insulin treated subjects with type 1 or type 2 diabetes.